D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CRBP holding history
Corbus Pharmaceuticals Holdings, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRBP overviewAll 13F holders of CRBPFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −26,474−100.0% | Sold out | Holders |
| Q1 2026 | 26,474 | $248.6K | <0.1% | −2,320−8.1% | Reduced | Holders |
| Q4 2025 | 28,794 | $234.4K | <0.1% | +18,167+171.0% | Added | Holders |
| Q3 2025 | 10,627 | $134.4K | <0.1% | +10,627 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −982,916−100.0% | Sold out | Holders |
| Q1 2022 | 982,916 | $522.0K | <0.1% | +163,410+19.9% | Added | Holders |
| Q4 2021 | 819,506 | $505.0K | <0.1% | +140,790+20.7% | Added | Holders |
| Q3 2021 | 678,716 | $692.0K | <0.1% | −36,719−5.1% | Reduced | Holders |
| Q2 2021 | 715,435 | $1.31M | <0.1% | +174,133+32.2% | Added | Holders |
| Q1 2021 | 541,302 | $1.07M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.